Skip to main content
Journal cover image

Etavopivat, an investigational, once-daily, selective pyruvate kinase-R activator, improves sickle red blood cell health and survival in patients with sickle cell disease: an analysis of exploratory studies in a phase 1 trial

Publication ,  Conference
Kalfa, TA; Telen, MJ; Saraf, SL; Brown, RC; Seu, KG; Larkin, SK; Soupene, E; Ribadeneira, MD; Schroeder, P; Wu, E; Kelly, P; Kuypers, FA
Published in: BRITISH JOURNAL OF HAEMATOLOGY
2022

Duke Scholars

Published In

BRITISH JOURNAL OF HAEMATOLOGY

EISSN

1365-2141

ISSN

0007-1048

Publication Date

2022

Volume

197

Start / End Page

12 / 13

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kalfa, T. A., Telen, M. J., Saraf, S. L., Brown, R. C., Seu, K. G., Larkin, S. K., … Kuypers, F. A. (2022). Etavopivat, an investigational, once-daily, selective pyruvate kinase-R activator, improves sickle red blood cell health and survival in patients with sickle cell disease: an analysis of exploratory studies in a phase 1 trial. In BRITISH JOURNAL OF HAEMATOLOGY (Vol. 197, pp. 12–13).
Kalfa, Theodosia A., Marilyn J. Telen, Santosh L. Saraf, R Clark Brown, Katie Giger Seu, Sandra K. Larkin, Eric Soupene, et al. “Etavopivat, an investigational, once-daily, selective pyruvate kinase-R activator, improves sickle red blood cell health and survival in patients with sickle cell disease: an analysis of exploratory studies in a phase 1 trial.” In BRITISH JOURNAL OF HAEMATOLOGY, 197:12–13, 2022.
Kalfa TA, Telen MJ, Saraf SL, Brown RC, Seu KG, Larkin SK, Soupene E, Ribadeneira MD, Schroeder P, Wu E, Kelly P, Kuypers FA. Etavopivat, an investigational, once-daily, selective pyruvate kinase-R activator, improves sickle red blood cell health and survival in patients with sickle cell disease: an analysis of exploratory studies in a phase 1 trial. BRITISH JOURNAL OF HAEMATOLOGY. 2022. p. 12–13.
Journal cover image

Published In

BRITISH JOURNAL OF HAEMATOLOGY

EISSN

1365-2141

ISSN

0007-1048

Publication Date

2022

Volume

197

Start / End Page

12 / 13

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology